COVID-19 改变了代谢性疾病的思维和管理方式。
COVID-19 alters thinking and management in metabolic diseases.
机构信息
Diabetes Complications Research Centre, Conway Institute, University College Dublin, Dublin, Ireland.
出版信息
Nat Rev Endocrinol. 2021 Feb;17(2):71-72. doi: 10.1038/s41574-020-00449-y.
Abstract
Metabolic diseases emerged as important risk factors for severe COVID-19, but the mechanisms responsible remained unclear for some time. The severity of metabolic diseases was also associated with worse outcomes in patients with COVID-19, forcing clinicians to adjust their thinking on which patients with metabolic disease, but without COVID-19, to prioritize for treatment during and immediately after the pandemic.
摘要
代谢性疾病已成为严重 COVID-19 的重要危险因素，但这些疾病的发病机制在一段时间内仍不清楚。代谢性疾病的严重程度也与 COVID-19 患者的预后较差有关，这迫使临床医生调整思路，即在大流行期间和之后，优先考虑对哪些患有代谢性疾病但没有 COVID-19 的患者进行治疗。
Zotero 插件